Realta Investment Advisors Decreases Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Realta Investment Advisors trimmed its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 90.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 396 shares of the financial services provider’s stock after selling 3,721 shares during the quarter. Realta Investment Advisors’ holdings in iShares Biotechnology ETF were worth $53,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Golden State Wealth Management LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter valued at approximately $128,000. Strategic Financial Concepts LLC purchased a new position in shares of iShares Biotechnology ETF during the 4th quarter worth $1,375,000. Telos Capital Management Inc. grew its position in shares of iShares Biotechnology ETF by 1.9% during the 4th quarter. Telos Capital Management Inc. now owns 10,999 shares of the financial services provider’s stock valued at $1,454,000 after acquiring an additional 209 shares during the period. Nvwm LLC increased its stake in shares of iShares Biotechnology ETF by 96.4% in the 4th quarter. Nvwm LLC now owns 1,493 shares of the financial services provider’s stock worth $197,000 after purchasing an additional 733 shares in the last quarter. Finally, Massachusetts Wealth Management purchased a new stake in shares of iShares Biotechnology ETF in the 4th quarter worth $270,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Down 2.1 %

NASDAQ IBB opened at $137.67 on Friday. The business’s fifty day moving average is $136.22 and its 200 day moving average is $141.41. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.